glp-1 weight loss telehealth Pharma Turns to Direct-to-Consumer Telehealth: A Game Changer for Drug Marketing Featured GLP-1 Program 2026 |

7 For patients who stop treatment early, weight regain is common

6 Alternatively, some patients may be prescribed sulfonylureas or thiazolidiniones to improve insulin secretion, but both of these treatment options are associated with an elevated risk of heart failure making them unsuitable for use in patients with cardiovascular disease

With the development of genetic testing technologies such as genome-wide association studies (GWAS) and next-generation sequencing (NGS), it has been discovered that approximately 127 locus abnormalities in the human genome are associated with the onset and progression of obesity [4] , as along with more than 550 monogenic mutations related to obesity [5]

Savvidou, S

Her dermatologist explained that GLP-1 drugs dont attack hair folliclesinstead, her body interpreted the 35-pound weight loss in 12 weeks as a major stressor, triggering temporary shedding

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study